Business
GeneDx to Participate in Fall Investor Conferences
STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that
About this update from Genedx Holdings Corp.
[{"type":"text","content":" STAMFORD, Conn.--(BUSINESS WIRE)--\nGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:\n\n\n\nUBS Genomic Medicine Summit – August 13-14, 2024\nDana Point, California\nFuture of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT\n\n\n\nMorgan Stanley Healthcare Conference - September 4-6, 2024\nNew York, New York\n\n\n\nWells Fargo Healthcare Conference - September 4-6, 2024\nBoston, Massachusetts\nFireside chat on Thursday, September 5 at 8:45 a.m. ET\n\n\n\nJefferies London Healthcare Conference - November 19-21, 2024\nLondon, England\n\n\n\nLive and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.\n\n\nAbout GeneDx\n\n\nAt GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/\n\nInvestor Relations Contact:\[email protected]\n\nMedia Contact:\[email protected]\n\n\nSource: GeneDx","length":4604,"tagName":"div"}]